Delos Wealth Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$565K Hold
2,313
0.32% 45
2025
Q4
$479K Sell
2,313
-85
-4% -$16.8K 0.32% 41
2025
Q3
$445K Sell
2,398
-212
-8% -$36.3K 0.3% 42
2025
Q2
$399K Hold
2,610
0.31% 42
2025
Q1
$433K Buy
2,610
+80
+3% +$12.5K 0.34% 42
2024
Q4
$366K Buy
2,530
+80
+3% +$12.4K 0.29% 41
2024
Q3
$397K Buy
2,450
+905
+59% +$144K 0.35% 44
2024
Q2
$226K Buy
1,545
+1,500
+3,333% +$223K 0.22% 51
2024
Q1
$7.12K Buy
45
+16
+55% +$2.55K 0.01% 136
2023
Q4
$4.55K Sell
29
-420
-94% -$64.4K 0.01% 114
2023
Q3
$72.6K Hold
449
0.09% 58
2023
Q2
$74.3K Hold
449
0.09% 56
2023
Q1
$69.6K Hold
449
0.09% 55
2022
Q4
$79.3K Hold
449
0.12% 52
2022
Q3
$73K Buy
449
+4
+0.9% +$677 0.09% 51
2022
Q2
$79K Hold
445
0.09% 50
2022
Q1
$79K Sell
445
-158
-26% -$26.9K 0.08% 63
2021
Q4
$103K Buy
603
+578
+2,312% +$94.6K 0.1% 49
2021
Q3
$4K Hold
25
﹤0.01% 123
2021
Q2
$4K Buy
+25
New +$4.14K 0.01% 119

Other funds holding JNJ

Delos Wealth Advisors's JNJ Position: Q1 2026 in Review

Delos Wealth Advisors held its Johnson & Johnson (JNJ) position steady in Q1 2026 at 2,313 shares worth $565K. The position accounts for 0.32% of the portfolio, ranked #45.

Delos Wealth Advisors first reported a position in JNJ in Q2 2021 and has held it in 20 quarters since. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Delos Wealth Advisors held 2,313 shares of Johnson & Johnson worth $565K as of Q1 2026.
  • Delos Wealth Advisors left its Johnson & Johnson share count unchanged in Q1 2026.
  • Johnson & Johnson made up 0.32% of Delos Wealth Advisors's portfolio in Q1 2026, its #45 holding.
  • Delos Wealth Advisors first reported a position in Johnson & Johnson in Q2 2021 and has held it in 20 quarters since.
  • 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Delos Wealth Advisors's 13F filing for Q1 2026, filed 14 May 2026.